Cargando…

Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts

Anemia is a relatively common symptom coexisting with colorectal carcinoma. Besides having a positive impact on hematological parameters, erythropoietin (Epo) has the serious adverse effect of promoting the neoplastic process. The role of Epo in colon cancer has not been clearly shown. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tankiewicz-Kwedlo, A., Hermanowicz, J., Surażynski, A., Rożkiewicz, D., Pryczynicz, A., Domaniewski, T., Pawlak, K., Kemona, A., Pawlak, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021757/ https://www.ncbi.nlm.nih.gov/pubmed/27543111 http://dx.doi.org/10.1007/s11010-016-2779-x

Ejemplares similares

Simultaneous use of erythropoietin and LFM‐A13 as a new therapeutic approach for colorectal cancer
por: Tankiewicz‐Kwedlo, Anna, et al.
Publicado: (2018)

The intensification of anticancer activity of LFM-A13 by erythropoietin as a possible option for inhibition of breast cancer
por: Rozkiewicz, Dariusz, et al.
Publicado: (2020)

Erythropoietin Intensifies the Proapoptotic Activity of LFM-A13 in Cells and in a Mouse Model of Colorectal Cancer
por: Tankiewicz-Kwedlo, Anna, et al.
Publicado: (2018)

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
por: Awida, Zamzam, et al.
Publicado: (2022)

Synthesis and cellular effects of novel 1,3,5-triazine derivatives in DLD and Ht-29 human colon cancer cell lines
por: Wróbel, Agnieszka, et al.
Publicado: (2019)

Erythropoietin (EPO) in acute kidney injury
por: Moore, Elizabeth, et al.
Publicado: (2011)

Erythropoietin drives breast cancer progression by activation of its receptor EPOR
por: Chan, Ka Kui, et al.
Publicado: (2017)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

A truncating mutation in EPOR leads to hypo-responsiveness to erythropoietin with normal haemoglobin
por: Oskarsson, Gudjon R., et al.
Publicado: (2018)

Regulation of Erythropoietin Receptor Activity in Endothelial Cells by Different Erythropoietin (EPO) Derivatives: An in Vitro Study
por: Trincavelli, Maria Letizia, et al.
Publicado: (2013)

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)

Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis
por: Hardee, M E, et al.
Publicado: (2005)

Comparison of Neurite Outgrowth Induced by Erythropoietin (EPO) and Carbamylated Erythropoietin (CEPO) in Hippocampal Neural Progenitor Cells
por: Oh, Dong Hoon, et al.
Publicado: (2012)

Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPα
por: Pinto, Jorge P., et al.
Publicado: (2008)

EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2018)

Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
por: Soliz, Jorge, et al.
Publicado: (2020)

Kynurenines as a Novel Target for the Treatment of Malignancies
por: Mor, Adrian, et al.
Publicado: (2021)

Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer
por: Wesolowski, Jakub, et al.
Publicado: (2022)

The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite – 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease
por: Pawlak, Dariusz, et al.
Publicado: (2016)

Crosstalk between Tryptophan Metabolism via Kynurenine Pathway and Carbohydrate Metabolism in the Context of Cardio-Metabolic Risk—Review
por: Kiluk, Małgorzata, et al.
Publicado: (2021)

Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders
por: Mor, Adrian, et al.
Publicado: (2021)

EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis
por: Hidalgo, Daniel, et al.
Publicado: (2021)

The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p
por: Chen, Zhimin, et al.
Publicado: (2018)

Local YB-1, Epo, and EpoR concentrations in fractured bones: results from a porcine model of multiple trauma
por: Bläsius, Felix Marius, et al.
Publicado: (2023)

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
por: Våtsveen, Thea Kristin, et al.
Publicado: (2016)

Author Correction: EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2019)

Dynamic Ligand Modulation of EPO Receptor Pools, and Dysregulation by Polycythemia-Associated EPOR Alleles
por: Singh, Seema, et al.
Publicado: (2012)

Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
por: Vetro, Calogero, et al.
Publicado: (2022)

Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma
por: Ribatti, D, et al.
Publicado: (2007)

Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma
por: Ribatti, D, et al.
Publicado: (2007)

The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia
por: Landau, Daniel, et al.
Publicado: (2018)

Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO)
por: Kausar, Humera, et al.
Publicado: (2011)

Neurobehavioral effects of uremic toxin–indoxyl sulfate in the rat model
por: Karbowska, Malgorzata, et al.
Publicado: (2020)

Generation of transgenic chickens expressing the human erythropoietin (hEPO) gene in an oviduct-specific manner: Production of transgenic chicken eggs containing human erythropoietin in egg whites
por: Kwon, Mo Sun, et al.
Publicado: (2018)

r.hu-Erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline
por: Tapolyai, Mihály, et al.
Publicado: (2003)

Comparative Study of Recombinant Human Erythropoietin (rhEPO) Products on CKD (Chronic Kidney Disease) Patients
por: Dwitanto, Kuspuji, et al.
Publicado: (2023)

Structural Identification of Modified Amino Acids on the Interface between EPO and Its Receptor from EPO BRP, Human Recombinant Erythropoietin by LC/MS Analysis
por: Song, Kwang-Eun, et al.
Publicado: (2014)

Suppression of NLRP3 Inflammasome by Erythropoietin via the EPOR/JAK2/STAT3 Pathway Contributes to Attenuation of Acute Lung Injury in Mice
por: Cao, Fei, et al.
Publicado: (2020)

The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?
por: Lamon, Séverine, et al.
Publicado: (2013)

Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration
por: Wang, Guan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2ckmkeh88v6mmlnaleqf41lkp0